Della Torre E, Feeney E, Deshpande V, Mattoo H, Mahajan V, Kulikova M, et al. B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease. Ann Rheum Dis. 2015;74:2236-43 pubmed publisher

Bendall S, Simonds E, Qiu P, Amir E, Krutzik P, Finck R, et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science. 2011;332:687-96 pubmed publisher

Arvindam U, van Hauten P, Schirm D, Schaap N, Hobo W, Blazar B, et al. A trispecific killer engager molecule against CLEC12A effectively induces NK-cell mediated killing of AML cells. Leukemia. 2021;35:1586-1596 pubmed publisher

Chen Z, Wang L, Gu L, Qu R, Lowrie D, Hu Z, et al. Decreased Expression of CD69 on T Cells in Tuberculosis Infection Resisters. Front Microbiol. 2020;11:1901 pubmed publisher

Ramkumar P, Abarientos A, Tian R, Seyler M, Leong J, Chen M, et al. CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma. Blood Adv. 2020;4:2899-2911 pubmed publisher

Buteyn N, Fatehchand K, Santhanam R, Fang H, Dettorre G, Gautam S, et al. Anti-leukemic effects of all-trans retinoic acid in combination with Daratumumab in acute myeloid leukemia. Int Immunol. 2018;30:375-383 pubmed publisher

Zeng W, Liu Z, Liu X, Zhang S, Khanniche A, Zheng Y, et al. Distinct Transcriptional and Alternative Splicing Signatures of Decidual CD4+ T Cells in Early Human Pregnancy. Front Immunol. 2017;8:682 pubmed publisher

Inui M, Sugahara Tobinai A, Fujii H, Itoh Nakadai A, Fukuyama H, Kurosaki T, et al. Tolerogenic immunoreceptor ILT3/LILRB4 paradoxically marks pathogenic auto-antibody-producing plasmablasts and plasma cells in non-treated SLE. Int Immunol. 2016;28:597-604 pubmed publisher

Long B, Stoddart C. Alpha interferon and HIV infection cause activation of human T cells in NSG-BLT mice. J Virol. 2012;86:3327-36 pubmed publisher

Luni C, Zagallo M, Albania L, Piccoli M, Pozzobon M, De Coppi P, et al. Design of a stirred multiwell bioreactor for expansion of CD34+ umbilical cord blood cells in hypoxic conditions. Biotechnol Prog. 2011;27:1154-62 pubmed publisher